These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11283127

  • 1. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
    Schneider DT, Wessalowski R, Calaminus G, Pape H, Bamberg M, Engert J, Waag K, Gadner H, Göbel U.
    J Clin Oncol; 2001 Apr 01; 19(7):1951-60. PubMed ID: 11283127
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug 01; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 4. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
    Wessalowski R, Blohm M, Calaminus G, Engert J, Harms D, Krause I, Kruck H, Grüttner HP, Pape H, Göbel U.
    Klin Padiatr; 1997 Aug 01; 209(4):250-6. PubMed ID: 9293458
    [Abstract] [Full Text] [Related]

  • 5. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Aug 01; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 6. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Aug 01; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 7. Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96.
    Schneider DT, Calaminus G, Reinhard H, Gutjahr P, Kremens B, Harms D, Göbel U.
    J Clin Oncol; 2000 Feb 01; 18(4):832-9. PubMed ID: 10673525
    [Abstract] [Full Text] [Related]

  • 8. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.
    Onkologie; 2011 Feb 01; 34(8-9):416-20. PubMed ID: 21934340
    [Abstract] [Full Text] [Related]

  • 9. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U, Bamberg M, Calaminus G, Gnekow AK, Herrmann HD, Lenard HG, Spaar HJ, Niethammer D, Kühl J, Harms D.
    Klin Padiatr; 1993 Feb 01; 205(4):217-24. PubMed ID: 7690863
    [Abstract] [Full Text] [Related]

  • 10. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U.
    Klin Padiatr; 2002 Feb 01; 214(4):173-8. PubMed ID: 12165898
    [Abstract] [Full Text] [Related]

  • 11. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R.
    N Engl J Med; 2007 Jul 26; 357(4):340-8. PubMed ID: 17652649
    [Abstract] [Full Text] [Related]

  • 12. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
    Biskup W, Calaminus G, Schneider DT, Leuschner I, Göbel U.
    Klin Padiatr; 2006 Jul 26; 218(6):303-8. PubMed ID: 17080331
    [Abstract] [Full Text] [Related]

  • 13. Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase I/II study in ten children and adolescents with recurrent or refractory tumors.
    Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U.
    Cancer; 1998 Feb 15; 82(4):793-800. PubMed ID: 9477114
    [Abstract] [Full Text] [Related]

  • 14. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C, Orbach D, Cropet C, Baranzelli MC, Martelli H, Thebaud E, Vérité C, Rome A, Fasola S, Corradini N, Rocourt N, Frappaz D, Kalfa N, Patte C.
    Pediatr Blood Cancer; 2014 Feb 15; 61(2):253-9. PubMed ID: 23940114
    [Abstract] [Full Text] [Related]

  • 15. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M, Tryakin A, Kanagavel D, Bulanov A, Burova A, Figurin K, Fainshtein I, Sergeev U, Zakharova T, Garin A, Tjulandin S.
    Urol Oncol; 2013 May 15; 31(4):499-504. PubMed ID: 21803619
    [Abstract] [Full Text] [Related]

  • 16. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P, Haas RJ, Göbel U, Calaminus G.
    Klin Padiatr; 2002 May 15; 214(4):167-72. PubMed ID: 12165897
    [Abstract] [Full Text] [Related]

  • 17. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.
    Göbel U, Calaminus G, Schneider DT, Koch S, Teske C, Harms D.
    Klin Padiatr; 2006 May 15; 218(6):309-14. PubMed ID: 17080332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.